摘要:Fostering translational research of advanced therapies has become a major priority
of both scientific community and national governments. Advanced therapy medicinal products
(ATMP) are a new medicinal product category comprising gene therapy and cell-based medicinal
products as well as tissue engineered medicinal products. ATMP development opens novel avenues
for therapeutic approaches in numerous diseases, including cancer and neurodegenerative and cardiovascular
diseases. However, there are important bottlenecks for their development due to the
complexity of the regulatory framework, the high costs and the needs for good manufacturing practice
(GMP) facilities and new end-points for clinical experimentation. Thus, a strategic cooperation
between different stakeholders (academia, industry and experts in regulatory issues) is strongly
needed. Recently, a great importance has been given to research infrastructures dedicated to foster
translational medicine of advanced therapies. Some ongoing European initiatives in this field are
presented and their potential impact is discussed.
关键词:Key words: translational research, advanced therapy medicinal products, research infrastructures.